Financial reports
NT 10-Q
Notice of late quarterly filing
15 Aug 23
NT 10-Q
Notice of late quarterly filing
16 May 23
NT 10-K
Notice of late annual filing
13 Apr 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
10-Q
2021 Q1
Quarterly report
17 May 21
Current reports
8-K
Bankruptcy or Receivership
25 Sep 23
8-K
Other Events
12 Jun 23
8-K
Entry into a Material Definitive Agreement
24 Apr 23
8-K
Entry into a Material Definitive Agreement
18 Apr 23
8-K
Other Events
10 Apr 23
8-K
Other Events
5 Apr 23
8-K
Lucira Health Announces Fda Authorization of FirstĀ & Only At-home Combination COVID-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
27 Feb 23
8-K
Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
22 Feb 23
8-K
Departure of Directors or Certain Officers
21 Feb 23
8-K
Departure of Directors or Certain Officers
13 Jan 23
Registration and prospectus
15-12G
Securities registration termination
4 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 23
25-NSE
Exchange delisting
12 Apr 23
S-8
Registration of securities for employees
11 Apr 22
S-8
Registration of securities for employees
8 Feb 21
424B4
Prospectus supplement with pricing info
8 Feb 21
S-1MEF
Registration of additional securities for an S-1
4 Feb 21
8-A12B
Registration of securities on exchange
1 Feb 21
S-1/A
IPO registration (amended)
1 Feb 21
Other
SEC STAFF
SEC staff action: Order
11 Feb 21
EFFECT
Notice of effectiveness
5 Feb 21
CERT
Certification of approval for exchange listing
4 Feb 21
CORRESP
Correspondence with SEC
2 Feb 21
CORRESP
Correspondence with SEC
2 Feb 21
SEC STAFF
SEC staff action: Order
2 Feb 21
CORRESP
Correspondence with SEC
25 Jan 21
CORRESP
Correspondence with SEC
15 Jan 21
UPLOAD
Letter from SEC
11 Jan 21
UPLOAD
Letter from SEC
18 Dec 20
Ownership
4
Erik T. Engelson
13 Mar 23
4
Richard Clavano Narido
13 Mar 23
4
Kevin Walter Collins
13 Mar 23
4
Anthony Joseph Allen
13 Mar 23
4
Ghazi Kashmolah
21 Feb 23
SC 13D/A
EPIQ Capital Group, LLC
22 Dec 22
4
Anthony Joseph Allen
22 Dec 22
4
Chad Boeding
16 Dec 22
4
Anthony Joseph Allen
9 Dec 22
4
Ghazi Kashmolah
9 Dec 22